Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| FOREX / NAME | Price $ | Chg $ | Chg % |
| CADCHF | 0.60 | 0.01 | +1.00% |
| Canadian Dollar - Switzerland Franc | |||
| DUST | 31.85 | 0.10 | +0.31% |
| Direxion Daily Gold Miners Bear 2X ETF | |||
| EUSA | 96.49 | 0.22 | +0.23% |
| iShares MSCI USA Equal Weighted ETF | |||
| SSFI | 21.11 | -0.02 | -0.08% |
| Day Hagan Smart Sector Fixed Income ETF | |||
| AIVL | 110.07 | -0.11 | -0.10% |
| WisdomTree US Al Enhanced Val ETF | |||
A.I.dvisor indicates that over the last year, NOXOF has been loosely correlated with NWPHF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NOXOF jumps, then NWPHF could also see price increases.
| Ticker / NAME | Correlation To NOXOF | 1D Price Change % | ||
|---|---|---|---|---|
| NOXOF | 100% | N/A | ||
| NWPHF - NOXOF | 54% Loosely correlated | N/A | ||
| NTRB - NOXOF | 29% Poorly correlated | -1.72% | ||
| BCRX - NOXOF | 26% Poorly correlated | -2.71% | ||
| IKT - NOXOF | 23% Poorly correlated | +1.83% | ||
| EYEN - NOXOF | 21% Poorly correlated | -1.80% | ||
More | ||||